Navigation Links
Trial to Test Gene Therapy for Angina in Women
Date:9/4/2007

ight need to be treated differently than men.

The Associated Press reported that a small study of 184 women conducted by Dr. Eva Swahn of the department of cardiology at University Hospital in Linkoping, Sweden, found that women who had major heart operations like a coronary bypass were more likely than men to die.

Although experts said no conclusions could be drawn from the finding, they agreed that the idea that women might need different heart disease treatment than men should be studied further, according to the AP.

More information

The full story of angina, its causes, symptoms and treatment, is provided by the U.S. National Library of Medicine.



SOURCES: Randall Moreadith, M.D., Ph.D., chief medical officer, and Christopher J. Reinhard, chief executive officer, Cardium Therapeutics Inc., San Diego; Suzanne Steinbaum, M.D., director, women and heart disease, Lenox Hill Hospital, New York City; Sept. 11, 2007, Journal of the American College of Cardiology


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Man against HIV – new vaccine ready for human trials
2. Male contraceptive in trial
3. How do patients benefit of clinical trials
4. Phase 3 trials of two multi-kinase inhibitors against cancer
5. Glenmark’s new molecule to go through trial
6. Clinical trials need to be more frank
7. First head-to-head trials of once weekly Fosamax and Actonel therapies
8. Hormone Replacement Therapy increases the risk of endometrial cancer
9. Atrial fibrillation predicts for acute ischaemic stroke
10. Spray on contraceptive clears Phase I trial
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...published in the Journal of Vertebral Subluxation ...ay offer significant benefits //to children suffer...research was conducted by Swiss chiropractor Yanni...ropractic Pediatric Association, who specializes i...
...h finding indicates that patients who were affecte...pse of multiple sclerosis (MS). Multiple Sclerosis...sheath that covers the nerve fibres. // Jorge Corr...ea Institute for Neurological Research in Buenos A...
...ered the fray of painkillers, especially the likes...relieve muscle soreness after a heavy work out or ...ine //equivalent of two cups of coffee, consumed b... by 50%. In the words of researcher Patrick O'Con...
... strain brought havoc to human community by killin...strain of virus was highly lethal and the affected...rein the defense mechanism of the body itself prov...cted. American researchers reconstructed this vir...
Other Medicine News:Health News:Chiropractic Care Helps Children With Learning Disorders and Dyslexia 2Health News:Chiropractic Care Helps Children With Learning Disorders and Dyslexia 3Health News:Work-outs, Not So Much of a ‘pain’ With Caffei 2
(Date:8/18/2008)...ewswire-USNewswire/ -- Boston University and Aubre...r for Human Genetics, Inc.,("CHG") and Director of...y,announced that CHG will no longer offer testing...agnostics, Inc., These patented tests include tes...1555G or Connexin 26 mutations, developmental diso...
(Date:8/18/2008)...al Trials Phase of Test Development Program, ORAN...-- Beckman,Coulter, Inc. (NYSE: BEC ) announced t...S. royalty obligation to Nephromics LLC, a Chestnu...lth. The license is for tests,related to the detec...ia, a,leading cause of maternal death. In addition...
(Date:8/18/2008)...18 /- Micromet, Inc.,(Nasda... novel, proprietary,antibodies for the treatment o...ll host a webcast and conference call this morning...ime (4:00 p.m. Central European,Time) to discuss t...urnal,SCIENCE on August 15, 2008., To access the ...
(Date:8/14/2008)...- AstraZeneca (NYSE: AZN )...h the National Cancer,Centre Singapore (NCCS) and ...anti-cancer compounds. The collaboration, which is...that was signed today, aims to further,build Astra... ultimately,speed up access to new medicines of po...
Breaking Medicine Technology:Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 1Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 2Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 3National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 1National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 1Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 1First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 2First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 4
...zation with a Bavituximab Equivalent and Irradiate...From 0% in Controls in a,Preclinical Model of Brai...18, 2007,/PRNewswire-FirstCall/ -- Peregrine Pharm...cal company developing targeted,monoclonal antibod...rus (HCV) infection, today announced preclinical s...
..., Wash., April 18, 2007 /PRNewswire-FirstCall/ -- ...Falla, Ph.D, Chief,Scientific Officer, will presen...ll molecule peptide (lipohexapeptide) technology,a... will take place,at the Boston Convention & Ex... 9th. Dr. Falla,s presentation is scheduled for,We...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 2Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 4
Latex agglutination inhibition slide test for the qualitative detection of hCG in urine.
Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum.
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood.
Color-enhanced slide agglutination test for the rapid qualitative and semi-quantitative detection of antistreptolysin O.
Medicine Products: